Monique C Minnema

InstitutionUMC Utrecht Cancer Center
Addressthe
Netherlands
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 2 Covid-19 publications, with a maximum of 2 publications in July 2020
    All Publications
    Bar chart showing 59 publications over 14 distinct years, with a maximum of 13 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Talaulikar D, Advani RH, Branagan AR, Buske C, Dimopoulos MA, D'Sa S, Kersten MJ, Leblond V, Minnema MC, Owen RG, Palomba ML, Tedeschi A, Trotman J, Varettoni M, Vos JM, Treon SP, Kastritis E, Castillo JJ. Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 Pandemic. Hemasphere. 2020 Aug; 4(4):e433. PMID: 32803133.
      Citations: 2   Article has an altmetric score of 15    
    2. Kastritis E, Wechalekar A, Schönland S, Sanchorawala V, Merlini G, Palladini G, Minnema M, Roussel M, Jaccard A, Hegenbart U, Kumar S, Cibeira MT, Blade J, Dimopoulos MA. Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemic. Br J Haematol. 2020 08; 190(3):346-357. PMID: 32480420.
      Citations: 4   Article has an altmetric score of 7    Fields:    Translation:HumansCellsPHPublic Health
    3. Schulthess D, Gassull D, Makady A, Ludlow A, Rothman B, Have PT, Wu Y, Ekstrom L, Minnema M, Jagasia M. Are CAR-T therapies living up to their hype? A study using real-world data in two cohorts to determine how well they are actually working in practice compared with bone marrow transplants. BMJ Evid Based Med. 2021 Jun; 26(3):98-102. PMID: 31315904.
      Citations: 3   Article has an altmetric score of 9    Fields:    Translation:HumansCells
    4. Braham MVJ, Alblas J, Dhert WJA, Öner FC, Minnema MC. Possibilities and limitations of an in vitro three-dimensional bone marrow model for the prediction of clinical responses in patients with relapsed multiple myeloma. Haematologica. 2019 11; 104(11):e523-e526. PMID: 31004023.
      Citations: 1   Article has an altmetric score of 1    Fields:    Translation:Humans
    5. Wester R, van der Holt B, Asselbergs E, Zweegman S, Kersten MJ, Vellenga E, van Marwijk Kooy M, de Weerdt O, Minnema M, Lonergan S, Palumbo A, Lokhorst H, Broijl A, Sonneveld P. Phase II study of carfilzomib, thalidomide, and low-dose dexamethasone as induction and consolidation in newly diagnosed, transplant eligible patients with multiple myeloma; the Carthadex trial. Haematologica. 2019 11; 104(11):2265-2273. PMID: 30948492.
      Citations: 6   Article has an altmetric score of 7    Fields:    Translation:HumansCTClinical Trials
    6. Plesner T, Arkenau HT, Gay F, Minnema MC, Boccadoro M, Moreau P, Cavenagh J, Perrot A, Laubach JP, Krejcik J, Ahmadi T, de Boer C, Chen D, Chiu C, Schecter JM, Richardson PG. Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma (GEN503): final results of an open-label, phase 1/2 study. Br J Haematol. 2019 08; 186(3):e35-e39. PMID: 30931524.
      Citations: 7   Article has an altmetric score of 1    Fields:    Translation:HumansCTClinical Trials
    7. Minnema MC, Nasserinejad K, Hazenberg B, Hegenbart U, Vlummens P, Ypma PF, Kröger N, Wu KL, Kersten MJ, Schaafsma MR, Croockewit S, de Waal E, Zweegman S, Tick L, Broijl A, Koene H, Bos G, Sonneveld P, Schönland S. Bortezomib-based induction followed by stem cell transplantation in light chain amyloidosis: results of the multicenter HOVON 104 trial. Haematologica. 2019 11; 104(11):2274-2282. PMID: 30923094.
      Citations: 9   Article has an altmetric score of 12    Fields:    Translation:HumansCTClinical Trials
    8. Bromberg JEC, Issa S, Bakunina K, Minnema MC, Seute T, Durian M, Cull G, Schouten HC, Stevens WBC, Zijlstra JM, Baars JW, Nijland M, Mason KD, Beeker A, van den Bent MJ, Beijert M, Gonzales M, de Jong D, Doorduijn JK. Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study. Lancet Oncol. 2019 02; 20(2):216-228. PMID: 30630772.
      Citations: 37   Article has an altmetric score of 56    Fields:    Translation:HumansCTClinical Trials
    9. Rutten KHG, Raymakers RAP, Hazenberg BPC, Nienhuis HLA, Vellenga E, Minnema MC. Haematological response and overall survival in two consecutive Dutch patient cohorts with AL amyloidosis diagnosed between 2008 and 2016. Amyloid. 2018 Dec; 25(4):227-233. PMID: 30513220.
      Citations: 2   Article has an altmetric score of 1    Fields:    Translation:Humans
    10. Braham MV, Deshantri AK, Minnema MC, Öner FC, Schiffelers RM, Fens MH, Alblas J. Liposomal drug delivery in an in vitro 3D bone marrow model for multiple myeloma. Int J Nanomedicine. 2018; 13:8105-8118. PMID: 30555229.
      Citations: 4   Fields:    Translation:HumansCells
    11. Hiemcke-Jiwa LS, Leguit RJ, Jiwa NM, Huibers MMH, Minnema MC. CXCR4 mutations in lymphoplasmacytic lymphoma lead to altered CXCR4 expression. Br J Haematol. 2019 06; 185(5):966-969. PMID: 30408147.
      Citations: Article has an altmetric score of 1    Fields:    Translation:HumansCells
    12. Hiemcke-Jiwa LS, Leguit RJ, Snijders TJ, Bromberg JEC, Nierkens S, Jiwa NM, Minnema MC, Huibers MMH. MYD88 p.(L265P) detection on cell-free DNA in liquid biopsies of patients with primary central nervous system lymphoma. Br J Haematol. 2019 06; 185(5):974-977. PMID: 30408153.
      Citations: 9   Article has an altmetric score of 1    Fields:    Translation:Humans
    13. Bollen L, Dijkstra SPD, Bartels RHMA, de Graeff A, Poelma DLH, Brouwer T, Algra PR, Kuijlen JMA, Minnema MC, Nijboer C, Rolf C, Sluis T, Terheggen MAMB, van der Togt-van Leeuwen ACM, van der Linden YM, Taal W. Clinical management of spinal metastases-The Dutch national guideline. Eur J Cancer. 2018 11; 104:81-90. PMID: 30336360.
      Citations: 10   Article has an altmetric score of 1    Fields:    Translation:Humans
    14. van de Donk NW, van der Holt B, Minnema MC, Vellenga E, Croockewit S, Kersten MJ, von dem Borne PA, Ypma P, Schaafsma R, de Weerdt O, Klein SK, Delforge M, Levin MD, Bos GM, Jie KG, Sinnige H, Coenen JL, de Waal EG, Zweegman S, Sonneveld P, Lokhorst HM. Thalidomide before and after autologous stem cell transplantation in recently diagnosed multiple myeloma (HOVON-50): long-term results from the phase 3, randomised controlled trial. Lancet Haematol. 2018 Oct; 5(10):e479-e492. PMID: 30290905.
      Citations: 5   Article has an altmetric score of 1    Fields:    Translation:HumansCTClinical Trials
    15. Oostvogels R, Jak M, Raymakers R, Mous R, Minnema MC. Efficacy of retreatment with immunomodulatory drugs and proteasome inhibitors following daratumumab monotherapy in relapsed and refractory multiple myeloma patients. Br J Haematol. 2018 10; 183(1):60-67. PMID: 30080247.
      Citations: 6   Article has an altmetric score of 2    Fields:    Translation:Humans
    16. Buske C, Sadullah S, Kastritis E, Tedeschi A, García-Sanz R, Bolkun L, Leleu X, Willenbacher W, Hájek R, Minnema MC, Cheng M, Bilotti E, Graef T, Dimopoulos MA. Treatment and outcome patterns in European patients with Waldenström's macroglobulinaemia: a large, observational, retrospective chart review. Lancet Haematol. 2018 Jul; 5(7):e299-e309. PMID: 29958569.
      Citations: 6   Article has an altmetric score of 7    Fields:    Translation:Humans
    17. van Westrhenen A, Smidt LCA, Seute T, Nierkens S, Stork ACJ, Minnema MC, Snijders TJ. Diagnostic markers for CNS lymphoma in blood and cerebrospinal fluid: a systematic review. Br J Haematol. 2018 08; 182(3):384-403. PMID: 29808930.
      Citations: 14   Article has an altmetric score of 10    Fields:    Translation:Humans
    18. Groenen KHJ, van der Linden YM, Brouwer T, Dijkstra SPD, de Graeff A, Algra PR, Kuijlen JMA, Minnema MC, Nijboer C, Poelma DLH, Rolf C, Sluis T, Terheggen MAMB, van der Togt-van Leeuwen ACM, Bartels RHMA, Taal W. The Dutch national guideline on metastases and hematological malignancies localized within the spine; a multidisciplinary collaboration towards timely and proactive management. Cancer Treat Rev. 2018 Sep; 69:29-38. PMID: 29870874.
      Citations: 5   Article has an altmetric score of 1    Fields:    Translation:Humans
    19. Hiemcke-Jiwa LS, Leguit RJ, Snijders TJ, Jiwa NM, Kuiper JJW, de Weger RA, Minnema MC, Huibers MMH. Molecular analysis in liquid biopsies for diagnostics of primary central nervous system lymphoma: Review of literature and future opportunities. Crit Rev Oncol Hematol. 2018 Jul; 127:56-65. PMID: 29891112.
      Citations: 14   Article has an altmetric score of 3    Fields:    Translation:HumansCells
    20. Braham MVJ, Ahlfeld T, Akkineni AR, Minnema MC, Dhert WJA, Öner FC, Robin C, Lode A, Gelinsky M, Alblas J. Endosteal and Perivascular Subniches in a 3D Bone Marrow Model for Multiple Myeloma. Tissue Eng Part C Methods. 2018 05; 24(5):300-312. PMID: 29652626.
      Citations: 8   Article has an altmetric score of 5    Fields:    Translation:HumansCells
    21. Braham MVJ, Minnema MC, Aarts T, Sebestyen Z, Straetemans T, Vyborova A, Kuball J, Öner FC, Robin C, Alblas J. Cellular immunotherapy on primary multiple myeloma expanded in a 3D bone marrow niche model. Oncoimmunology. 2018; 7(6):e1434465. PMID: 29872571.
      Citations: 18   Article has an altmetric score of 12    
    22. Hiemcke-Jiwa LS, Minnema MC, Radersma-van Loon JH, Jiwa NM, de Boer M, Leguit RJ, de Weger RA, Huibers MMH. The use of droplet digital PCR in liquid biopsies: A highly sensitive technique for MYD88 p.(L265P) detection in cerebrospinal fluid. Hematol Oncol. 2018 Apr; 36(2):429-435. PMID: 29210102.
      Citations: 34   Article has an altmetric score of 7    Fields:    Translation:Humans
    23. Vos JM, Notermans NC, D'Sa S, Lunn MP, van der Pol WL, Kraan W, Reilly MM, Chalker J, Gupta R, Kersten MJ, Pals ST, Minnema MC. High prevalence of the MYD88 L265P mutation in IgM anti-MAG paraprotein-associated peripheral neuropathy. J Neurol Neurosurg Psychiatry. 2018 09; 89(9):1007-1009. PMID: 29018161.
      Citations: 3   Article has an altmetric score of 10    Fields:    Translation:Humans
    24. Hiemcke-Jiwa LS, Leguit RJ, Radersma-van Loon JH, Westerweel PE, Rood JJM, Doorduijn JK, Huibers MMH, Minnema MC. Efficacy of ibrutinib in a patient with transformed lymphoplasmacytic lymphoma and central nervous system involvement. Leuk Lymphoma. 2018 05; 59(5):1256-1259. PMID: 28849690.
      Citations: 2   Fields:    Translation:Humans
    25. Persoon S, ChinAPaw MJM, Buffart LM, Liu RDK, Wijermans P, Koene HR, Minnema MC, Lugtenburg PJ, Marijt EWA, Brug J, Nollet F, Kersten MJ. Randomized controlled trial on the effects of a supervised high intensity exercise program in patients with a hematologic malignancy treated with autologous stem cell transplantation: Results from the EXIST study. PLoS One. 2017; 12(7):e0181313. PMID: 28727771.
      Citations: 17   Article has an altmetric score of 8    Fields:    Translation:Humans
    26. Kumar S, Moreau P, Hari P, Mateos MV, Ludwig H, Shustik C, Masszi T, Spencer A, Hájek R, Romeril K, Avivi I, Liberati AM, Minnema MC, Einsele H, Lonial S, Berg D, Lin J, Gupta N, Esseltine DL, Richardson PG. Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma. Br J Haematol. 2017 08; 178(4):571-582. PMID: 28485007.
      Citations: 14   Article has an altmetric score of 2    Fields:    Translation:HumansCTClinical Trials
    27. Admiraal R, Nierkens S, de Witte MA, Petersen EJ, Fleurke GJ, Verrest L, Belitser SV, Bredius RGM, Raymakers RAP, Knibbe CAJ, Minnema MC, van Kesteren C, Kuball J, Boelens JJ. Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a multicentre, retrospective, pharmacodynamic cohort analysis. Lancet Haematol. 2017 Apr; 4(4):e183-e191. PMID: 28330607.
      Citations: 49   Article has an altmetric score of 41    Fields:    Translation:HumansCTClinical Trials
    28. Beijers AJ, Oerlemans S, Mols F, Eurelings M, Minnema MC, Vreugdenhil A, van de Poll-Franse LV. The magnitude of neurotoxicity in patients with multiple myeloma and the impact of dose modifications: results from the population-based PROFILES registry. Ann Hematol. 2017 Apr; 96(4):653-663. PMID: 28116479.
      Citations: 3   Article has an altmetric score of 4    Fields:    Translation:HumansPHPublic Health
    29. Minnema MC, Kimby E, D'Sa S, Fornecker LM, Poulain S, Snijders TJ, Kastritis E, Kremer S, Fitsiori A, Simon L, Davi F, Lunn M, Castillo JJ, Patterson CJ, Le Garff-Tavernier M, Costopoulos M, Leblond V, Kersten MJ, Dimopoulos MA, Treon SP. Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome. Haematologica. 2017 01; 102(1):43-51. PMID: 27758817.
      Citations: 17   Article has an altmetric score of 11    Fields:    Translation:Humans
    30. Plesner T, Arkenau HT, Gimsing P, Krejcik J, Lemech C, Minnema MC, Lassen U, Laubach JP, Palumbo A, Lisby S, Basse L, Wang J, Sasser AK, Guckert ME, de Boer C, Khokhar NZ, Yeh H, Clemens PL, Ahmadi T, Lokhorst HM, Richardson PG. Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma. Blood. 2016 10 06; 128(14):1821-1828. PMID: 27531679.
      Citations: 40   Article has an altmetric score of 27    Fields:    Translation:HumansCTClinical Trials
    31. Vos JM, Gustine J, Rennke HG, Hunter Z, Manning RJ, Dubeau TE, Meid K, Minnema MC, Kersten MJ, Treon SP, Castillo JJ. Renal disease related to Waldenström macroglobulinaemia: incidence, pathology and clinical outcomes. Br J Haematol. 2016 Nov; 175(4):623-630. PMID: 27468978.
      Citations: 21   Article has an altmetric score of 2    Fields:    Translation:Humans
    32. Verduyn Lunel FM, Raymakers R, van Dijk A, van der Wagen L, Minnema MC, Kuball J. Cytomegalovirus Status and the Outcome of T Cell-Replete Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2016 10; 22(10):1883-1887. PMID: 27470287.
      Citations: 4   Fields:    Translation:HumansCells
    33. Leblond V, Kastritis E, Advani R, Ansell SM, Buske C, Castillo JJ, García-Sanz R, Gertz M, Kimby E, Kyriakou C, Merlini G, Minnema MC, Morel P, Morra E, Rummel M, Wechalekar A, Patterson CJ, Treon SP, Dimopoulos MA. Treatment recommendations from the Eighth International Workshop on Waldenström's Macroglobulinemia. Blood. 2016 09 08; 128(10):1321-8. PMID: 27432877.
      Citations: 39   Article has an altmetric score of 34    Fields:    Translation:Humans
    34. Castillo JJ, Garcia-Sanz R, Hatjiharissi E, Kyle RA, Leleu X, McMaster M, Merlini G, Minnema MC, Morra E, Owen RG, Poulain S, Stone MJ, Tam C, Varettoni M, Dimopoulos MA, Treon SP, Kastritis E. Recommendations for the diagnosis and initial evaluation of patients with Waldenström Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenström Macroglobulinaemia. Br J Haematol. 2016 10; 175(1):77-86. PMID: 27378193.
      Citations: 15   Article has an altmetric score of 10    Fields:    Translation:Humans
    35. Nijhof IS, Casneuf T, van Velzen J, van Kessel B, Axel AE, Syed K, Groen RW, van Duin M, Sonneveld P, Minnema MC, Zweegman S, Chiu C, Bloem AC, Mutis T, Lokhorst HM, Sasser AK, van de Donk NW. CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma. Blood. 2016 08 18; 128(7):959-70. PMID: 27307294.
      Citations: 109   Article has an altmetric score of 37    Fields:    Translation:HumansCellsCTClinical Trials
    36. de Haart SJ, Holthof L, Noort WA, Minnema MC, Emmelot ME, Aarts-Riemens T, Doshi P, Sasser K, Yuan H, de Bruijn J, Martens AC, van de Donk NW, Lokhorst HM, Groen RW, Mutis T. Sepantronium bromide (YM155) improves daratumumab-mediated cellular lysis of multiple myeloma cells by abrogation of bone marrow stromal cell-induced resistance. Haematologica. 2016 08; 101(8):e339-42. PMID: 27151995.
      Citations: 12   Article has an altmetric score of 5    Fields:    Translation:HumansCells
    37. Caers J, Fernández de Larrea C, Leleu X, Heusschen R, Zojer N, Decaux O, Kastritis E, Minnema M, Jurczyszyn A, Beguin Y, Wäsch R, Palumbo A, Dimopoulos M, Mateos MV, Ludwig H, Engelhardt M. The Changing Landscape of Smoldering Multiple Myeloma: A European Perspective. Oncologist. 2016 Mar; 21(3):333-42. PMID: 26921288.
      Citations: 12   Article has an altmetric score of 5    Fields:    Translation:Humans
    38. Castillo JJ, D'Sa S, Lunn MP, Minnema MC, Tedeschi A, Lansigan F, Palomba ML, Varettoni M, Garcia-Sanz R, Nayak L, Lee EQ, Rinne ML, Norden AD, Ghobrial IM, Treon SP. Central nervous system involvement by Waldenström macroglobulinaemia (Bing-Neel syndrome): a multi-institutional retrospective study. Br J Haematol. 2016 Mar; 172(5):709-15. PMID: 26686858.
      Citations: 17   Article has an altmetric score of 7    Fields:    Translation:Humans
    39. Lokhorst HM, van der Holt B, Cornelissen JJ, Kersten MJ, van Oers M, Raymakers R, Minnema MC, Zweegman S, Bos G, Schaap N, Wittebol S, de Weerdt O, Ammerlaan R, Sonneveld P. Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival. Haematologica. 2015 Dec; 100(12):e508-10. PMID: 26341740.
      Citations: 4   Article has an altmetric score of 4    Fields:    Translation:HumansCTClinical Trials
    40. Lokhorst HM, Plesner T, Laubach JP, Nahi H, Gimsing P, Hansson M, Minnema MC, Lassen U, Krejcik J, Palumbo A, van de Donk NW, Ahmadi T, Khan I, Uhlar CM, Wang J, Sasser AK, Losic N, Lisby S, Basse L, Brun N, Richardson PG. Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma. N Engl J Med. 2015 Sep 24; 373(13):1207-19. PMID: 26308596.
      Citations: 346   Article has an altmetric score of 206    Fields:    Translation:HumansCTClinical Trials
    41. Meijer WJ, Kromdijk W, van den Broek MP, Haas PJ, Minnema MC, Boucher CA, de Lange DW, Wensing AM. Treatment of Immunocompromised, Critically Ill Patients with Influenza A H1N1 Infection with a Combination of Oseltamivir, Amantadine, and Zanamivir. Case Rep Infect Dis. 2015; 2015:504975. PMID: 26346659.
      Citations: 3   
    42. Vos JM, Kersten MJ, Kraan W, Groeneveld ON, Linn C, Pals ST, Minnema MC. Effective treatment of Bing-Neel Syndrome with oral fludarabine: a case series of four consecutive patients. Br J Haematol. 2016 Feb; 172(3):461-4. PMID: 25944724.
      Citations: 6   Article has an altmetric score of 2    Fields:    Translation:Humans
    43. Voermans NC, Benveniste O, Minnema MC, Lokhorst H, Lammens M, Meersseman W, Delforge M, Kuntzer T, Novy J, Pabst T, Bouhour F, Romero N, Leblond V, Bergh Pv, Vekemans MC, van Engelen BG, Eymard B. Sporadic late-onset nemaline myopathy with MGUS: long-term follow-up after melphalan and SCT. Neurology. 2014 Dec 02; 83(23):2133-9. PMID: 25378674.
      Citations: 12   Article has an altmetric score of 4    Fields:    Translation:Humans
    44. Oostvogels R, Lokhorst HM, Minnema MC, van Elk M, van den Oudenalder K, Spierings E, Mutis T, Spaapen RM. Identification of minor histocompatibility antigens based on the 1000 Genomes Project. Haematologica. 2014 Dec; 99(12):1854-9. PMID: 25150256.
      Citations: 15   Fields:    Translation:Humans
    45. de Haart SJ, van de Donk NW, Minnema MC, Huang JH, Aarts-Riemens T, Bovenschen N, Yuan H, Groen RW, McMillin DW, Jakubikova J, Lokhorst HM, Martens AC, Mitsiades CS, Mutis T. Accessory cells of the microenvironment protect multiple myeloma from T-cell cytotoxicity through cell adhesion-mediated immune resistance. Clin Cancer Res. 2013 Oct 15; 19(20):5591-601. PMID: 24004671.
      Citations: 26   Article has an altmetric score of 8    Fields:    Translation:HumansAnimalsCells
    46. Minnema MC, de Keizer B. False-positive PET scan after bone marrow biopsy. Br J Haematol. 2013 Jun; 161(6):753. PMID: 23647318.
      Fields:    Translation:Humans
    47. Regelink JC, Minnema MC, Terpos E, Kamphuis MH, Raijmakers PG, Pieters-van den Bos IC, Heggelman BG, Nievelstein RJ, Otten RH, van Lammeren-Venema D, Zijlstra JM, Arens AI, de Rooy JW, Hoekstra OS, Raymakers R, Sonneveld P, Ostelo RW, Zweegman S. Comparison of modern and conventional imaging techniques in establishing multiple myeloma-related bone disease: a systematic review. Br J Haematol. 2013 Jul; 162(1):50-61. PMID: 23617231.
      Citations: 59   Article has an altmetric score of 24    Fields:    Translation:Humans
    48. van Galen KP, van Dijk J, Regelink JC, Huijgens PC, Minnema MC, Zweegman S. Implantable defibrillators in cardiac amyloidosis. Int J Cardiol. 2013 May 10; 165(2):371-3. PMID: 22989609.
      Fields:    Translation:Humans
    49. Lokhorst HM, van der Holt B, Cornelissen JJ, Kersten MJ, van Oers M, Raymakers R, Minnema MC, Zweegman S, Janssen JJ, Zijlmans M, Bos G, Schaap N, Wittebol S, de Weerdt O, Ammerlaan R, Sonneveld P. Donor versus no-donor comparison of newly diagnosed myeloma patients included in the HOVON-50 multiple myeloma study. Blood. 2012 Jun 28; 119(26):6219-25; quiz 6399. PMID: 22442350.
      Citations: 40   Article has an altmetric score of 10    Fields:    Translation:HumansCTClinical Trials
    50. van der Helm LH, Alhan C, Wijermans PW, van Marwijk Kooy M, Schaafsma R, Biemond BJ, Beeker A, Hoogendoorn M, van Rees BP, de Weerdt O, Wegman J, Libourel WJ, Luykx-de Bakker SA, Minnema MC, Brouwer RE, Croon-de Boer F, Eefting M, Jie KS, van de Loosdrecht AA, Koedam J, Veeger NJ, Vellenga E, Huls G. Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programme. Br J Haematol. 2011 Dec; 155(5):599-606. PMID: 21981697.
      Citations: 35   Fields:    Translation:HumansCellsCTClinical Trials
    51. Janssen A, van der Bruggen T, Haas PJ, de Jong PA, Minnema MC. Comparison of the occurrence of mold infection among patients receiving chemotherapy for acute leukemia versus patients undergoing stem cell transplantation. Eur J Haematol. 2011 Nov; 87(5):419-25. PMID: 21732981.
      Citations: 2   Article has an altmetric score of 2    Fields:    Translation:Humans
    52. Kneppers E, van der Holt B, Kersten MJ, Zweegman S, Meijer E, Huls G, Cornelissen JJ, Janssen JJ, Huisman C, Cornelisse PB, Bruijnen CP, Emmelot M, Sonneveld P, Lokhorst HM, Mutis T, Minnema MC. Lenalidomide maintenance after nonmyeloablative allogeneic stem cell transplantation in multiple myeloma is not feasible: results of the HOVON 76 Trial. Blood. 2011 Sep 01; 118(9):2413-9. PMID: 21690556.
      Citations: 61   Article has an altmetric score of 10    Fields:    Translation:HumansCTClinical Trials
    53. van Dorp S, Resemann H, te Boome L, Pietersma F, van Baarle D, Gmelig-Meyling F, de Weger R, Petersen E, Minnema M, Lokhorst H, Ebeling S, Beijn SJ, Knol EF, van Dijk M, Meijer E, Kuball J. The immunological phenotype of rituximab-sensitive chronic graft-versus-host disease: a phase II study. Haematologica. 2011 Sep; 96(9):1380-4. PMID: 21546493.
      Citations: 4   Fields:    Translation:HumansCellsCTClinical Trials
    54. Pietersma FL, van Dorp S, Minnema MC, Kuball J, Meijer E, Schuurman R, van Baarle D. Influence of donor cytomegalovirus (CMV) status on severity of viral reactivation after allogeneic stem cell transplantation in CMV-seropositive recipients. Clin Infect Dis. 2011 Apr 01; 52(7):e144-8. PMID: 21427386.
      Citations: 4   Article has an altmetric score of 3    Fields:    Translation:HumansCells
    55. Kneppers E, Lokhorst HM, Eeltink CM, Huls G, Kersten MJ, Koedam J, Minnema MC, van Oers MH, Raymakers RA, Schaafsma MR, Vellenga E, Wijermans PW, Wittebol S, Sonneveld P, Zweegman S. Analysis of efficacy and prognostic factors of lenalidomide treatment as part of a Dutch compassionate use program. Clin Lymphoma Myeloma Leuk. 2010 Apr; 10(2):138-43. PMID: 20371448.
      Citations: 6   Article has an altmetric score of 3    Fields:    Translation:Humans
    56. van de Donk NW, Wittebol S, Minnema MC, Lokhorst HM. Lenalidomide (Revlimid) combined with continuous oral cyclophosphamide (endoxan) and prednisone (REP) is effective in lenalidomide/dexamethasone-refractory myeloma. Br J Haematol. 2010 Jan; 148(2):335-7. PMID: 20085583.
      Citations: 10   Fields:    Translation:Humans
    57. Lokhorst HM, van der Holt B, Zweegman S, Vellenga E, Croockewit S, van Oers MH, von dem Borne P, Wijermans P, Schaafsma R, de Weerdt O, Wittebol S, Delforge M, Berenschot H, Bos GM, Jie KS, Sinnige H, van Marwijk-Kooy M, Joosten P, Minnema MC, van Ammerlaan R, Sonneveld P. A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma. Blood. 2010 Feb 11; 115(6):1113-20. PMID: 19880501.
      Citations: 76   Article has an altmetric score of 9    Fields:    Translation:HumansCTClinical Trials
    58. Spaapen RM, Lokhorst HM, van den Oudenalder K, Otterud BE, Dolstra H, Leppert MF, Minnema MC, Bloem AC, Mutis T. Toward targeting B cell cancers with CD4+ CTLs: identification of a CD19-encoded minor histocompatibility antigen using a novel genome-wide analysis. J Exp Med. 2008 Nov 24; 205(12):2863-72. PMID: 19001137.
      Citations: 28   Article has an altmetric score of 3    Fields:    Translation:HumansCells
    59. van Marion AM, Auwerda JJ, Minnema MC, van Oosterom R, Adelmeijer J, de Groot PG, Leebeek FW, Sonneveld P, Lokhorst HM, Lisman T. Hypofibrinolysis during induction treatment of multiple myeloma may increase the risk of venous thrombosis. Thromb Haemost. 2005 Dec; 94(6):1341-3. PMID: 16411420.
      Citations: 7   Fields:    Translation:HumansCTClinical Trials